MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
SPLS
PIMCO US Stocks PLUS Active Bond Exchange Traded Fund
There isn't enough reported data to score SPLS yet.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
SPLS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
SPLS's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like SPLS.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
SPLS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 84x | $54.42 | -0.5% |
| Current | 84x | $54.70 | — |
| Fair | 85x | $55.09 | +0.7% |
| Expensive | 85x | $55.47 | +1.4% |
Historical ranges are pointers, not guarantees.
SPLS has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
SPLS Forward outlook
There aren't enough analyst estimates for SPLS to show an outlook.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the stronger earnings trend. Trailing diluted EPS is up 29% for MS versus SPLS down 21%.
SPLS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2014 | $0.82 | +$1.11 |
| Q2 2014 | $0.85 | +$1.12 |
| Q1 2014 | $0.96 | +$1.22 |
| Q4 2013 | $0.75 | +2400% |
| Q3 2013 | -$0.29 | -122% |
| Q2 2013 | -$0.27 | -119% |
| Q1 2013 | -$0.26 | -118% |
| Q4 2012 | $0.03 | -98% |
SPLS's earnings per share have fallen from their peak: $0.65 over the past year, against $1.41 in early 2012.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the stronger quarterly revenue trend. Revenue is up 12% for MS versus down 18% for SPLS.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
SPLS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2017 | $3.9B | -18% |
| Q2 2017 | $4.1B | -19% |
| Q1 2017 | $3B | -42% |
| Q3 2016 | $4.8B | -3.7% |
| Q2 2016 | $5.1B | -3.1% |
| Q1 2016 | $5.3B | -6.9% |
| Q3 2015 | $4.9B | -5.4% |
| Q2 2015 | $5.3B | -6.9% |
SPLS's revenue has slid since its 2011 peak: $3.9B last quarter, down 18% from the same quarter a year ago.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
SPLS has the stronger cash trend. Its trailing FCF is up 31% versus its history, compared with MS at down 492%.
SPLS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2017 | -$31M | +$314M |
| Q2 2017 | $221M | -4.7% |
| Q1 2017 | $207M | +90% |
| Q3 2016 | -$345M | -$267M |
| Q2 2016 | $232M | -3.3% |
| Q1 2016 | $109M | +$134M |
| Q3 2015 | -$78M | +$40M |
| Q2 2015 | $240M | -23% |
SPLS's free cash flow was $982M over the past year, against −$82M the year before. Free cash flow isn't a meaningful measure for financial services companies like SPLS.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over SPLS on shareholder dilution, with a more favorable share count trend.
SPLS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +1M shares |
| 1 year | +1.7% | +11M shares |
| 3 years | -0.1% | -442K shares |
| 5 years | -6.5% | -46M shares |
| Available history | -10% | -72.9M shares |
SPLS has 658M diluted shares, up 1.7% from a year ago.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
SPLS Net Leverage
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
SPLS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.6 | Neutral |
| Stochastic | 31.7 | Neutral |
SPLS's weekly RSI is 67 (neutral) and its Stochastic is 32 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over SPLS on valuation relative to its sector.
SPLS PE vs Financial Services Sector
| Metric | SPLS | Sector median | Relative |
|---|---|---|---|
| PE | 84x | 13x | 543% above |
SPLS is trading at 84x earnings, a 543% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has stronger trend alignment. MS is above 3 of 5 weekly averages versus SPLS above 2 of 4.
SPLS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $54.9 | 0.4% below |
| 20 week MA | $55.0 | 0.5% below |
| 50 week MA | $39.0 | 40% above |
| 100 week MA | $24.0 | 128% above |
SPLS has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 128% above its 100-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.
SPLS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2016 | $9.62 | $9.22 | -4.2% |
| 2017 | $9.22 | $10.3 | +11% |
| 2026 YTD | $10.3 | $54.7 | +434% |
SPLS has the edge over MS on returns for 2026, with the stronger performance.